gvtcx

Supply of Targeted Cell Lineage Separation

3149053 Published 20 Mar 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£250,732
Statuscomplete
Category (CPV) 38434540
Deadline1 Jun 2022
Contract start1 Jul 2022
Contract end30 Jun 2026
Procedureselective
SME suitableNo
OCIDocds-b5fd17-0c09d219-6414-4c87-8ccf-d150898cbe50

Award

SupplierValueDateStatus
MILTENYI BIOTEC LIMITED £250,000 31 May 2022 active

description

NHSBT has a requirement for targeted cell lineage separation for use within NHSBT Diagnostic Functions.

NHSBT must to be able to perform targeted cell lineage separation:

To ensure that NHSBT meet its legal duties and complies with all regulatory and internal quality procedures for diagnostic testing and to ensure best value for money

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
20 Mar 2023 Award (award) · cac5e8ab-5697-4d28-a0ce-a1633938ec54-625978

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.